CANCvsGNMXETF Comparison
VS
Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of CANC and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CANC vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC GNMX | -0.28%-4.64% | +8.61%n/a | +18.41%n/a | +53.77%n/a | n/an/a | n/an/a |
| Flows | CANC GNMX | -$2M- | +$3M- | +$52M- | +$76M- | -- | -- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC GNMX | +23.01%n/a | +22.71%n/a | n/an/a | n/an/a |
| Max drawdown | CANC GNMX | -5.93%n/a | -9.20%n/a | n/an/a | n/an/a |
| Max drawdown duration | CANC GNMX | 47dn/a | 67dn/a | n/an/a | n/an/a |
Trading data
CANC | GNMX | |
Last sale 7/28/2026 at 1:30 PM | $41.18 | |
| Previous close 07/27/2026 | $41.10 | |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
CANC | GNMX | |
|---|---|---|
| Last price | $41.18 | – |
| 1D performance | +0.20% | – |
| AuM | $195.62 M | $1.63 M |
| E/R | 0.99% | 0.35% |
Characteristics
CANC | GNMX | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Tema | Corgi Funds |
| Benchmark | - | - |
| N° of holdings | 56 | 57 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 15, 2023 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
CANC
USA
80.59%
Switzerland
9.85%
Other
9.56%
GNMX
USA
89.37%
Other
10.63%
Sectors
CANC
Healthcare
99.28%
Other
0.72%
GNMX
Healthcare
98.21%
Other
1.79%
Advertisement
Diversification
CANC
Total weight of top 15 holdings out of 15
55.76%
GNMX
Total weight of top 15 holdings out of 15
53.1%
Top 15 holdings
Data as of June 30, 2026
CANC
Revolution Medicines, Inc.
6.32%
Eli Lilly & Co.
5.24%
Cogent Biosciences, Inc.
4.94%
Novartis AG
4.19%
Roche Holding AG
3.93%
Legend Biotech Corp.
3.70%
Merck & Co., Inc.
3.66%
Bristol Myers Squibb Co.
3.33%
AstraZeneca PLC
3.15%
Johnson & Johnson
3.09%
AbbVie, Inc.
3.08%
Immunome, Inc.
2.87%
Exelixis, Inc.
2.85%
Nuvalent, Inc.
2.73%
IDEAYA Biosciences, Inc.
2.68%
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
Frequently asked questions about CANC and GNMX
Which ETF is bigger: CANC or GNMX?
As of July 27, 2026, CANC holds $195.62 M in assets under management (AUM), while GNMX manages $1.63 M.
What sectors do the CANC and GNMX ETFs invest in?
CANC leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the CANC ETF and GNMX ETF?
CANC top holdings include Revolution Medicines, Inc., Eli Lilly & Co. and Cogent Biosciences, Inc.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc..
Which ETF is more diversified: CANC or GNMX?
CANC holds 56 securities with 55.76% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 53.1%.
Advertisement
Advertisement
